[1]周 璇,邹 娟,谢 莉,等.慢性阻塞性肺疾病急性加重期患者CT肺血管参数与肺功能及预后相关性分析[J].陕西医学杂志,2023,52(5):587-590,617.[doi:DOI:10.3969/j.issn.1000-7377.2023.05.021]
　ZHOU Xuan,ZOU Juan,XIE Li,et al.Correlation between CT pulmonary vascular parameters and pulmonary function,prognosis in AECOPD patients[J].,2023,52(5):587-590,617.[doi:DOI:10.3969/j.issn.1000-7377.2023.05.021]
点击复制

慢性阻塞性肺疾病急性加重期患者CT肺血管参数与肺功能及预后相关性分析
分享到：

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
52
期数:
2023年5期
页码:
587-590,617
栏目:
临床研究
出版日期:
2023-05-05

文章信息/Info

Title:
Correlation between CT pulmonary vascular parameters and pulmonary function,prognosis in AECOPD patients
作者:
周 璇; 邹 娟; 谢 莉; 寇 咏
(四川大学华西医院呼吸综合科,四川 成都 610044)
Author(s):
ZHOU Xuan; ZOU Juan; XIE Li; KOU Yong
(Department of General Respiratory,West China Hospital,Sichuan University,Chengdu 610044,China)
关键词:
慢性阻塞性肺疾病;  计算机断层扫描;  肺小血管面积;  肺动脉和主动脉直径比值;  肺功能;  预后
Keywords:
Chronic obstructive pulmonary disease;  Computed tomography;  Pulmonary small vessel area;  Ratio of pulmonary artery to aorta diameter;  Pulmonary function;  Prognosis
分类号:
R 563.9
DOI:
DOI:10.3969/j.issn.1000-7377.2023.05.021
文献标志码:
A
摘要:
目的:探讨慢性阻塞性肺疾病急性加重期(AECOPD)患者CT肺血管参数与肺功能及预后的相关性。方法:选取146例AECOPD患者作为AECOPD组,选取同期健康体检者85例作为CR组,比较两组CT肺血管参数[肺小血管面积百分比(%CSA)、肺动脉和主动脉直径比值(PA/A)]、肺功能指标[用力肺活量(FVC)、第1秒用力呼气容积(FEV1)、第1秒用力呼气容积与用力肺活量的百分比(FEV1/FVC)],并分析其与预后的相关性。结果:AECOPD组%CSA、FVC、FEV1、FEV1/FVC水平低于CR组,PA/A水平高于CR组(均P<0.05); Pearson相关性分析显示,%CSA与FVC、FEV1、FEV1/FVC呈正相关,PA/A与FVC、FEV1、FEV1/FVC呈负相关(均P<0.05); 生存组%CSA水平高于死亡组,PA/A水平低于死亡组(均P<0.05); ROC曲线分析显示,%CSA、PA/A联合预测AECOPD患者预后的AUC为0.871,高于%CSA的0.770,PA/A的0.784(均P<0.05); 采用二元Logistic回归分析,年龄>60岁(OR=4.181,P=0.003)、糖尿病(OR=4.412,P=0.010)、GOLD分级Ⅲ-Ⅳ级(OR=3.050,P=0.019)、%CSA≤1.57%(OR=2.965,P=0.020)、PA/A>0.94(OR=3.967,P=0.005)均为AECOPD患者预后的独立危险因素(P<0.05)。结论:AECOPD患者CT肺血管参数与肺功能及预后有相关性,%CSA≤1.57%、PA/A>0.94是AECOPD患者预后的独立危险因素。
Abstract:
Objective:To explore the correlation between CT pulmonary vascular parameters and pulmonary function,prognosis in patients with acute exacerbation of chronic obstructive pulmonary disease(AECOPD).Methods:A total of 146 patients with AECOPD were enrolled as AECOPD group,while 85 healthy controls during the same period were enrolled as CR group.CT pulmonary vascular parameters [percentage of pulmonary small vessel area(%CSA),ratio of pulmonary artery to aorta diameter(PA/A)]and pulmonary function indexes [forced vital capacity(FVC),forced expiratory volume in one second(FEV1),FEV1/FVC]were compared between the two groups,and their correlation with prognosis was analyzed.Results:The levels of%CSA,FVC,FEV1 and FEV1/FVC in AECOPD group were lower than those in CR group,while PA/A was higher than that in CR group(all P<0.05).Pearson correlation analysis showed that%CSA was positively correlated with FVC,FEV1 and FEV1/FVC,while PA/A was negatively correlated with them(all P<0.05).%CSA in survival group was higher than that in CR group,while PA/A level was lower than that in CR group(all P<0.05).ROC curve analysis showed that the AUC of%CSA combined with PA/A in predicting the prognosis of AECOPD patients was 0.871,higher than that of %CSA(0.770)and PA/A(0.784)(all P<0.05).Binary Logistic regression analysis showed that age >60 years(OR=4.181,P=0.003),diabetes mellitus(OR=4.412,P=0.010),GOLD grading at grade Ⅲ-Ⅳ(OR=3.050,P=0.019),%CSA ≤1.57%(OR=2.965,P=0.020)and PA/A >0.94(OR=3.967,P=0.005)were independent risk factors of prognosis in patients with AECOPD.Conclusion:CT pulmonary vascular parameters are correlated with pulmonary function and prognosis in AECOPD patients.%CSA ≤1.57% and PA/A >0.94 are independent risk factors of prognosis in AECOPD patients.

参考文献/References:

[1] 杜沂岚,唐 敏,陈朝晖,等.经肺腧穴中药离子导入联合振动排痰治疗慢性阻塞性肺疾病急性加重期临床疗效[J].陕西中医,2020,41(4):534-537.
[2] Agustí A,Hogg JC.Update on the pathogenesis of chronic obstructive pulmonary disease[J].New England Journal of Medicine,2019,381(13):1248-1256.
[3] Ritchie AI,Wedzicha JA.Definition,causes,pathogenesis,and consequences of chronic obstructive pulmonary disease exacerbations[J].Clinics in Chest Medicine,2020,41(3):421-438.
[4] 方利文,王临虹,吴 静.慢性阻塞性肺疾病患者诊断,治疗与管理状况监测评估[J].中华流行病学杂志,2020,41(7):109-1013.
[5] 慢性阻塞性肺疾病急性加重(AECOPD)诊治专家组.慢性阻塞性肺疾病急性加重(AECOPD)诊治中国专家共识(2017年更新版)[J].国际呼吸杂志,2017,37(14):1041-1057.
[6] 陈新民,江 晨.年龄呼吸困难指数气流受限程度指数在慢性阻塞性肺疾病患者远期预后评估中的价值[J].安徽医学,2020,41(2):170-172.
[7] 张志平,王耀东,叶 珣.AECOPD患者胸部高分辨率CT检查图像肺血管参数变化及其与肺功能、短期预后的关系[J].山东医药,2020,60(30):69-72.
[8] 王 超,许建英,武志峰,等.慢性阻塞性肺疾病急性加重期患者CT肺血管参数与病情严重程度的相关性研究[J].国际呼吸杂志,2019,39(7):515-520.
[9] 中华医学会,中华医学会杂志社,中华医学会全科医学分会,等.慢性阻塞性肺疾病基层诊疗指南(2018年)[J].中华全科医师杂志,2018,17(11):856-870.
[10] Deng L,Yan J,Xu H,et al.Prediction of exacerbation frequency of AECOPD based on next-generation sequencing and its relationship with imbalance of lung and gut microbiota:A protocol of a prospective cohort study[J].BMJ Open,2021,11(9):47202.
[11] 陈辅萍.慢性阻塞性肺疾病并发感染性肺炎危险因素分析[J].陕西医学杂志,2020,49(1):102-104.
[12] Kovacs G,Agusti A,Barberà JA,et al.Pulmonary vascular involvement in chronic obstructive pulmonary disease:Is there a pulmonary vascular phenotype?[J].American Journal of Respiratory and Critical Care Medicine,2018,198(8):1000-1011.
[13] 杨 诚.清肺化痰汤合桑白皮汤治疗慢性阻塞性肺疾病急性加重期痰热壅肺证疗效及对患者免疫功能的影响[J].陕西中医,2021,42(9):1223-1225.
[14] 陆金娟,齐 琳,张少杰.慢性阻塞性肺疾病定量CT参数与肺功能相关性的研究进展[J].实用放射学杂志,2022,38(1):152-155.
[15] 施烨琳,翟建审校,乔佳业,等.定量CT评估慢性阻塞性肺疾病的研究进展[J].国际医学放射学杂志,2021,44(2):183-187.
[16] 苏 勇,王 蕾,魏 卿.初探AECOPD患者MSCT容积成像指标与肺功能相关参数间的相关性[J].中国CT和MRI杂志,2020,18(11):73-76.
[17] 刘金良,庞 军,李晓冬,等.慢性阻塞性肺疾病患者胸部定量CT参数与肺功能检测指标相关性分析[J].临床肺科杂志,2020,25(12):1831-1835.
[18] 黄 耀,隋 昕,徐晓莉,等.慢性阻塞性肺疾病CT定量评估研究进展[J].医学综述,2019,25(7):1399-1403.
[19] 吴兴贵,张 博,连一新,等.探讨不同肺叶定量CT参数在慢性阻塞性肺疾病评估中的价值[J].南京医科大学学报:自然科学版,2020,40(3):396-402.
[20] Yang T,Chen C,Chen Z.The CT pulmonary vascular parameters and disease severity in COPD patients on acute exacerbation:A correlation analysis[J].BMC Pulmonary Medicine,2021,21(1):1-8.
[21] 余 刚,张飔雪.慢性阻塞性肺疾病急性加重期患者血清干扰素-γ、甲壳质酶蛋白-40水平及与预后、肺功能相关性分析[J].陕西医学杂志,2021,50(10):1223-1226.
[22] 阳廷亮,秦 岭.AECOPD患者CT肺血管参数与病情严重程度及血清尿酸的关系分析[J].中国CT和MRI杂志,2022,20(1):60-62.
[23] 吴新宇,宋丹丹,赵洪文.血清降钙素原指导AECOPD患者抗菌治疗疗效及预后的Meta分析[J].国际呼吸杂志,2022,42(4):250-261.

相似文献/References:

[1]马明铭,李 芳,杨 慧,等.噻托溴胺粉雾剂联合非药物康复方案对慢性阻塞性肺疾病患者BODE指数的影响[J].陕西医学杂志,2019,(4):515.
　MA Mingming,LI Fang,YANG Hui,et al.Effect of tiotropium bromide powder and nonpharmacological rehabilitation program on BODE index in patients with chronic obstructive pulmonary disease[J].,2019,(5):515.
[2]朱小川.血小板/淋巴细胞比值预测慢性阻塞性肺疾病急性加重期〖JZ〗伴有早期肾功能损害临床价值[J].陕西医学杂志,2019,(10):1353.
　ZHU Xiaochuan..Clinical value of platelet/lymphocyte ratio in predicting early renal impairment〖JZ〗 in acute exacerbation of chronic obstructive pulmonary disease[J].,2019,(5):1353.
[3]张军营.吸烟对慢阻肺患者血清S100A8/A9、8异前列腺素F2α、组织蛋白酶S及其它炎症因子表达水平的影响*[J].陕西医学杂志,2019,(11):1426.
[4]焦文妤,尚家璐,李树霞△.慢性阻塞性肺疾病患者血清补体C1q肿瘤坏死因子相关蛋白5与肺功能及炎症反应相关性研究[J].陕西医学杂志,2019,(12):1616.
[5]陈辅萍.慢性阻塞性肺疾病并发感染性肺炎危险因素分析[J].陕西医学杂志,2020,49(1):102.
[6]薛佩妮,冯敏娟△,王惠琴.噻托溴铵粉联合糖皮质激素治疗慢性阻塞性肺疾病疗效及对患者生活质量评分的影响*[J].陕西医学杂志,2020,49(2):216.
　XUE Peini,FENG Minjuan,WANG Huiqin..Efficacy of tiotropium bromide combined with glucocorticoids in the treatment of COPD and its effect on patients' quality of life score[J].,2020,49(5):216.
[7]焦文妤,高爱华△.血清可溶性髓系细胞触发受体-1与临床肺部感染评分在慢性阻塞性肺疾病呼吸机相关性肺炎早期诊断及预后判断中的效能研究[J].陕西医学杂志,2020,49(12):1630.[doi:DOI:10.3969/j.issn.1000-7377.2020.12.024]
　JIAO Wenyu,GAO Aihua..Effectiveness of sTREM-1 and CPIS in early diagnosis and prognosis judgment of ventilator-associated pneumonia in COPD[J].,2020,49(5):1630.[doi:DOI:10.3969/j.issn.1000-7377.2020.12.024]
[8]张卓红,赵拖利.慢性阻塞性肺疾病大鼠血液、支气管灌洗液中水通道蛋白及p-c-Jun-N-末端激酶表达情况实验研究[J].陕西医学杂志,2021,50(7):776.[doi:DOI:10.3969/j.issn.1000-7377.2021.07.002]
　ZHANG Zhuohong,ZHAO Tuoli.Expression of AQP-1 and p-JNK in blood and bronchial lavage fluid of rats with COPD[J].,2021,50(5):776.[doi:DOI:10.3969/j.issn.1000-7377.2021.07.002]
[9]余 刚,张飔雪.慢性阻塞性肺疾病急性加重期患者血清干扰素-γ、甲壳质酶蛋白-40水平及与预后、肺功能相关性分析[J].陕西医学杂志,2021,50(10):1223.[doi:DOI:10.3969/j.issn.1000-7377.2021.10.011]
　YU Gang,ZHANG Sixue.The levels of INF-γ and YKL-40 in patients with AECOPD and their correlation with prognosis and lung function[J].,2021,50(5):1223.[doi:DOI:10.3969/j.issn.1000-7377.2021.10.011]
[10]高延忠,王明利.CT联合MRI评估肝细胞癌病理分级可行性研究[J].陕西医学杂志,2022,51(3):375.[doi:DOI:10.3969/j.issn.1000-7377.2022.03.026]

备注/Memo

备注/Memo:
基金项目:四川省科技计划项目(2018SZ0240)
更新日期/Last Update: 2023-05-05